Profile
Henry M.
Dachowitz has been a Director of Lev Pharmaceuticals, Inc. since November 28, 2007 and an Independent Financial and Business Management Consultant since 2006.
He was Treasurer of Nassau County New York.
Mr. Dachowitz was an Auditor of Coopers & Lybrand, a Research Analyst with Sanford C.
Bernstein & Company and Chief Financial Officer of Pharmos Corporation.
He was a Member of the Student Advisory Committee of the Institute of Politics at the Kennedy School of Government at Harvard University and an Editorial Advisor of the Journal of Accountancy from 1989 to 1999.
Mr. Dachowitz is a Certified Public Accountant and received a Bachelor of Science degree from Brooklyn College and a Masters in Business Administration from Harvard Business School.
Former positions of Henry M. Dachowitz
| Companies | Position | End |
|---|---|---|
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Director/Board Member | 2008-10-21 |
Training of Henry M. Dachowitz
| Brooklyn College | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Health Technology |
- Stock Market
- Insiders
- Henry M. Dachowitz
